Article
ALDH1-Mediated Autophagy Sensitizes Glioblastoma Cells to Ferroptosis
12 Dec 2022
Abstract excerpt
The fatal clinical course of human glioblastoma (GBM) despite aggressive adjuvant therapies is due to high rates of recurrent tumor growth driven by tumor cells with stem-cell characteristics (glioma stem cells, GSCs). The aldehyde dehydrogenase 1 (ALDH1) family of enzymes has been shown to be a biomarker for GSCs, and ALDH1 seems to be involved in the biological processes causing therapy resistance. Ferroptosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
